{
    "eid": "2-s2.0-84923195602",
    "title": "A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: A randomized trial",
    "cover-date": "2014-11-01",
    "subject-areas": [
        {
            "$": "Obstetrics and Gynecology",
            "@code": "2729"
        },
        {
            "$": "Reproductive Medicine",
            "@code": "2743"
        }
    ],
    "keywords": [
        "Acne lesion",
        "Biphasic oral contraceptive",
        "Facial seborrhea",
        "Triphasic oral contraceptive"
    ],
    "authors": [
        "Unnop Jaisamrarn"
    ],
    "citedby-count": 19,
    "ref-count": 21,
    "ref-list": [
        "New treatments and therapeutic strategies for acne",
        "An update on the pathogenesis and management of acne vulgaris",
        "Effectiveness of oral contraceptives in the treatment of acne",
        "Examining the use of oral contraceptives in the management of acne",
        "Maturitas",
        "The phasic approach to oral contraception: The triphasic concept and its clinical application",
        "Comparative contraceptive efficacy and mechanism of action of the norgestimate\u2010containing triphasic oral contraceptive",
        "Efficacy and safety of a monophasic and a triphasic oral contraceptive containing norgestimate",
        "Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins",
        "Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial",
        "Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris",
        "Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives",
        "Serum concentrations of ethinylestradiol, 3-keto- desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrel",
        "Acne treatment with a new estroprogestinic biphasic combination containing desogestrel",
        "The Leeds revised acne grading system",
        "Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate",
        "The effect of a phasic oral contraceptive containing Desogestrel on seborrhea and acne",
        "Effects of two estroprogestins containing ethynilestradiol 30g and drospirenone 3mg and ethynilestradiol 30g and chlormadinone 2mg on skin and hormonal hyperandrogenic manifestations",
        "Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen",
        "Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara\u00ae) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial",
        "Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Siriraj Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chiang Mai",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Janssen-Cilag",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Janssen-Cilag Thailand"
    ]
}